Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei Article

De Stasio, G, Rajesh, D, Ford, JM et al. (2006). Motexafin-gadolinium taken up in vitro by at least 90% of glioblastoma cell nuclei . CLINICAL CANCER RESEARCH, 12(1), 206-213. 10.1158/1078-0432.CCR-05-0743

Open Access International Collaboration

cited authors

  • De Stasio, G; Rajesh, D; Ford, JM; Daniels, M; Erhardt, R; Frazer, BH; Tyliszczak, T; Gilles, MK; Conhaim, RL; Howard, SP; Fowler, JF; Esteve, F; Mehta, MP

sustainable development goals

authors

publication date

  • January 1, 2006

webpage

published in

keywords

  • ADVANCED LIGHT-SOURCE
  • AGENTS
  • BRAIN METASTASES
  • ENERGY
  • Life Sciences & Biomedicine
  • Oncology
  • RADIATION
  • RADIOTHERAPY
  • SYNCHROTRON X-RAYS
  • Science & Technology
  • TEXAPHYRINS
  • THERAPY
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 206

end page

  • 213

volume

  • 12

issue

  • 1